0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

[+] Author Affiliations

Section Editor: Robin L. Travers, MD


Arch Dermatol. 2007;143(8):974. doi:10.1001/archderm.143.8.974.
Text Size: A A A
Published online

TREATMENT OF SEVERE PEMPHIGUS WITH RITUXIMAB

Pemphigus is a mucocutaneous blistering disease mediated by circulating autoantibodies directed against desmogleins. Systemic steroids remain the mainstay of therapy, but adverse effects of corticosteroids and complications from long-term immunosuppressive therapy contribute substantially to the morbidity and mortality from this disease. Additional therapies include pulsed steroid administration, cyclophosphamide, plasmapheresis, intravenous immunoglobulins, and mycophenolate mofetil. In this case series, Cianchini et al demonstrate the safety, efficacy, and tolerability of the chimeric murine-human anti-CD20 monoclonal antibody rituximab in treating patients with pemphigus resistant to conventional therapy.

See Article

NEPHROGENIC SYSTEMIC FIBROSIS

Nephrogenic systemic fibrosis (NSF) is an acquired, progressive, systemic fibrosing disorder that develops in the setting of renal disease. Plaquelike woody induration of the skin may involve deeper tissues as well as systemic sites such as skeletal muscle, pericardium, lung, and dura mater. The fact that NSF appeared only within the past 10 years suggests a causal link to a new medication or chemical or infectious agent. In this case series, Richmond et al describe a cohort of 8 patients with NSF and an etiologic link with gadolinium contrast dye exposure, specifically gadodiamide. Extracorporeal photopheresis therapy proved useful by some objective measures of response.

See Article

NARROWBAND UV-B PHOTOTHERAPY, ALEFACEPT, AND CLEARANCE OF PSORIASIS

The classic erythematous plaques of psoriasis are clinical signs of chronic skin inflammation accompanied by hyperproliferation of keratinocytes and dermal infiltration by certain lymphocyte subtypes. A new generation of antipsoriatic drugs specifically target the T-cell–mediated pathways involved in the pathogenesis of this disease. Alefacept is an immunomodulatory, recombinant, fully human, fusion protein that targets the memory-effector T-cells implicated in sustaining psoriatic lesions. In this randomized half-side comparison study, Legat et al demonstrate the synergistic effect of alefacept with narrowband UV-B therapy in the treatment of psoriasis.

See Article

DISTANCE TO DIAGNOSING PROVIDER AS A MEASURE OF ACCESS FOR PATIENTS WITH MELANOMA

Survival for patients with melanoma is dependent on stage at diagnosis, and early diagnosis may substantially improve patient outcomes. Because melanoma can only be diagnosed definitively based on biopsy findings, diagnosis requires detection of suspicious lesions and subsequent biopsy. Although some primary care providers perform diagnostic biopsies, many prefer to refer patients to dermatologists or surgeons. Thus early diagnosis is dependent on access to specialists comfortable with diagnosing melanoma. In this analysis of all incident cases of melanoma in 2000 from 42 North Carolina counties, Stitzenberg et al demonstrate that Breslow thickness at diagnosis was directly related to distance to diagnosing provider, increasing 0.6% for every 1-mile increase in distance away from diagnosing provider. Once barriers to melanoma care are identified, interventions can be developed to minimize the effect of travel distance on access to melanoma care.

See Article

SKIN CANCER AWARENESS AND SUN PROTECTION BEHAVIORS IN WHITE HISPANIC AND WHITE NON-HISPANIC HIGH SCHOOL STUDENTS IN MIAMI, FLORIDA

Increasing incidence and delayed diagnosis of skin cancer in the rapidly growing Hispanic population in the United States represent an emerging health issue. While there are substantial data describing sun protection practices in white populations, data on awareness and risk perception in Hispanic populations are lacking. In this pilot survey study, Ma et al demonstrate that white Hispanic (WH) high school students were more likely to tan deeply than white non-Hispanic (WNH) students, and they were less likely to have heard of or been told how to perform skin self-examination. In additions, WH students were less likely to wear sun-protective clothing or sunscreens and were 2.5 times more likely than WNH students to have used a tanning bed. These disparities in knowledge, perceived risk, and sun-protective behaviors between WH and WNH students signal the need for primary and secondary prevention strategies directed toward Hispanic patients.

See Article

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

225 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs